Human medicines European public assessment report (EPAR): Simponi, golimumab, Arthritis, Psoriatic;S 13 november Human medicines European public assessment report (EPAR): Simponi, golimumab, Arthritis, Psoriatic;S Human medicines European public assessment report (EPAR): Simponi, golimumab, Arthritis, Psoriatic;Spondylitis, Ankylosing;Colitis, Ulcerative;Arthritis, Rheumatoid, Date of authorisation: 01/10/2009, Revision: 48, Status: Authorised Lees verder » Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief.